Former UFC heavyweight champion Junior dos Santos (18-5-0) was informed yesterday by the United States Anti-Doping Agency (USADA) of a potential anti-doping violation from an out-of-competition sample collected on Aug. 10.
The UFC released the following statement on its website.
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Junior Dos Santos of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collected on Aug. 10, 2017. Because of the proximity to Dos Santos’ upcoming scheduled bout at UFC 215 in Edmonton, Canada against Francis Ngannou, Dos Santos has been removed from the card and the UFC is currently seeking a replacement.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Dos Santos. Under the UFC Anti-Doping Policy, there is a full and fair legal process that is afforded to all athletes before any sanctions are imposed. Additional information will be provided at the appropriate time as the process moves forward.
Dos Santos rep Ana Claudia Guedes told MMAjunkie in a statement that Hydrocholorothiazide – typically used to control high blood pressure – was the cause of the positive test and that the matter is being looked into how it entered the system of dos Santos.
Ngannou took to Twitter upon learning of the withdrawal of dos Santos, but apparently spoke to dos Santos and cleared the air.
“Cigano,” 32, was trying to return to the win column after being stopped by champion Stipe Miocic at UFC 211. “The Predator,” 30, is undefeated after five bouts in the octagon, including an impressive win over former champion Andrei Arlovski at UFC on FOX 23 in January.
The process moves forward.